MOR MorphoSys AG ADRs

MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development. This is an ADR of a company whose stock trades outside of the U.S. as the symbol GF:MOR.

$13.65  -1.20 (-8.08%)
As of 07/27/2021 15:56:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Germany
Country of incorporation:  
IPO date:  04/19/2018
Outstanding shares:  131,570,160
Average volume:  104,231
Market cap:   $2,128,805,189
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    617760202
ISIN:        US6177602025
Sedol:      BZ2YT41
Valuation   (See tab for details)
PE ratio:   -11.07
PB ratio:   3.36
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy